Solutions Overview

The clinical landscape facing us today is more complicated, more expensive and arguably slower than ever before which means a new breed of product is required.

The FDA’s critical path initiative, the advent of new technology and the application of improved data management practices, allows Cmed to challenge the entire clinical trial process. Our strategy is to combine technology and people in a unique grouping – delivering true adaptive solutions, without the drama.

Our groundbreaking technology, Timaeus, has been developed with eSource specifically in mind. It can bring about the most profound change in the conduct of clinical trials for decades.